Preoperative localization of parathyroid lesions: Value of 99mTc-MIBI tomography and factors influencing detection

NuklearMedizin

Volumn 47, Issue 4, 2008, Pages 158-162

  Ansquer, Catherine ^a   Mirallie E ^a   Carlier, T ^a   Abbey Huguenin, H ^b,c   Aubron, F ^d   Kraeber Bodere F ^a  

^a HÔTEL DIEU   (France)

^b Rene Gauducheau Cancer Center   (France)

^c CHU DE NANTES   (France)

^d Ultrasonography Center   (France)

Author keywords

99mTc sestamibi; Hyperparathyroidism; Parathyroid scintigraphy; Preoperative localization; PTH; SPECT

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; O 4 TC 99M; PARATHYROID HORMONE; TECHNETIUM DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; CANCER LOCALIZATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORGAN WEIGHT; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROID HYPERPLASIA; PARATHYROID SCINTISCANNING; PEROPERATIVE ECHOGRAPHY; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SEX; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID NODULE;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PARATHYROID GLANDS; PARATHYROID NEOPLASMS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THYROID GLAND;

EID: 49449109226     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0108     Document Type: Article

References (21)

1. 201Tl in a tumour cell line. Nucl Med Commun 1997; 18: 235-240.
2. Benard F, Lefebvre B, Beuvon F et al. Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med 1995; 36: 241-243.
3. Bhatnagar A, Vezza PR, Bryan JA et al. Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability. J Nucl Med 1998 ;39: 1617-1620.
4. Billotey C, Sarfati E, Aurengo A et al. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy. J Nucl Med 1996; 11: 1773-1778.
5. Carpentier A, Jeannotte S, Verreault J et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 1998; 39: 1441-1444.
6. Chen CC, Holder LE, Scovill WA et al. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med 1997; 38: 834-839.
7. 99mTc sestamibi - a new agent for parathyroid imaging. Nucl Med Commun 1989; 10: 791-794.
8. Grant CS, Thompson G, Farley D et al. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 2005; 140: 472-478.
9. Hetrakul N, Civelek AC, Stagg CA et al. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria. Surgery 2001; 130: 1011-1018.
10. Kao A, Shiau YC, Tsai SC et al. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression. Eur J Nucl Med Mol Imaging 2002; 29: 1012-1015.
11. 99mTc- sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout. Eur J Nucl Med Mol Imaging 2002; 29: 1566-1570.
12. 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003; 44: 904-908.
13. McBiles M, Lambert AT, Cote MG et al. Sestamibi parathyroid imaging. Semin Nucl Med 1995; 25: 221-234.
14. Moka D, Voth E, Dietlein M et al. Technetium 99m-MIBI-SPECT: A highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 2000; 128: 29-35.
15. O'Doherty MJ, Kettle AG, Wells P et al. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992; 33: 313-318.
16. 99mTc sestamibi SPECT. Radiology 1996; 201: 85-91.
17. Rubello D, Gross MD, Mariani G et al. Scintigraphic techniques in primary hyperparathyroidism: from pre-operative localisation to intra-operative imaging. Eur J Nucl Med Mol Imaging. 2007; 34: 926-933.
18. rd, Foss J et al. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med 1996; 37: 798-804.
19. Staudenherz A, Abela C, Niederle B et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 1997; 24: 143-149.
20. Taillefer R, Boucher Y, Potvin C et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992; 33: 1801-1807.
21. Yamaguchi S, Yachiku S, Hashimoto H et al. Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands. World J Surg 2002; 26: 29-34.